TP53 codon 72 polymorphism and risk for cervical cancer in Portugal

Cancer Genetics and Cytogenetics

Volumn 159, Issue 2, 2005, Pages 143-147

  Santos, Alexandra M ^a   Sousa, Hugo ^a   Catarino, Raquel ^a   Pinto, Daniela ^a   Pereira, Deolinda ^a   Vasconcelos, André ^a   Matos, Ana ^a,b   Lopes, Carlos ^a   Medeiros, Rui ^a  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b Maternidade Júlio Dinis Maternity Porto ^*  (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER GRADING; CANCER RISK; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PORTUGAL; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU;

CODON; FEMALE; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PORTUGAL; RISK; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 19344362729     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2004.10.005     Document Type: Article

References (51)

1. S. Cannistra, and J. Niloff Cancer of the uterine cervix New Engl J Med 334 1996 1030 1038
2. P.S. Souza, de Araujo, and L.L. Villa Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil Mutat Res 544 2003 375 383
3. P.S. Pinheiro, J.E. Tyczynski, F. Bray, J. Amado, E. Matos, and D.M. Parkin Cancer incidence and mortality in Portugal Eur J Cancer 39 2003 2507 2520
4. S.M.F. Brenna, I.D.G.C. Silva, L.C. Zeferino, J.S. Pereira, E.Z. Martinez, and K.J. Syrjänen Prognostic value of P53 codon 72 polymorphism in invasive cervical cancer in Brazil Gynecol Oncol 93 2004 374 380
5. N. Muñoz Human papillomavirus and cancer: the epidemiological evidence J Clin Virol 19 2000 1 5
6. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer, and N. Munoz Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
7. E.L. Franco, T.E. Rohan, and L.L. Villa Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer J Natl Cancer Inst 91 1999 506 511
8. N. Muñoz, F.X. Bosch, S. de Sanjose, and K.V. Shan The role of HPV in the etiology of cervical cancer Mutat Res 305 1994 293 301
9. F.X. Bosch, M.M. Manos, N. Muñoz, M. Scherman, A.M. Jansen, J. Peto, M.H. Schiffman, V. Moreno, R. Kurman, and K.V. Shah Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group J Natl Cancer Inst 87 1995 796 802
10. J. Doorbar, and J.C. Sterling The biology of human papillomaviruses J.C. Sterling S.K. Tyring Human papillomaviruses: clinical and scientific advances 2001 Arnold London 10 23
11. D. Neves, G.N.L. Camara, T.R. Alencar, M.R. Da Cruz, C.R.F. Martins, and L.G.S. Carvalho Prevalence of human papillomavirus in penile carcinoma Braz J Urol 28 2002 221 226
12. P.A. Lazo The molecular genetics of cervical carcinoma Br J Cancer 80 1999 2008 2018
13. H. Makni, E.L. Franco, J. Kaiano, L.L. Villa, S. Labrecque, R. Dudley, A. Storey, and G. Matlashewski P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation Int J Cancer 87 2000 528 533
14. N. Soulitzis, G. Sourvinos, D.N. Dokianakis, and D.A. Spandidos p53 codon 72 polymorphism and its association with bladder cancer Cancer Lett 179 2002 175 183
15. M. Scheffner, B.A. Werness, J.M. Huibregtse, A.J. Levine, and P.M. Howley The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129 1136
16. M. Tommasino, R. Accardi, S. Caldeira, W. Dong, I. Malanchi, A. Smet, and I. Zehbe The role of TP53 in cervical carcinogenesis Hum Mutat 21 2003 307 312
17. A. Storey, M. Thomas, A. Kalita, C. Harwood, D. Gardiol, F. Mantovani, J. Breuer, I.M. Leigh, G. Matlashewski, and L. Banks Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 393 1998 229 234
18. P. Tenti, N. Vesentini, M. Rondo Spaudo, R. Zappatore, P. Migliora, I. Carnevali, and G.N. Ranzani p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy Cancer Epidemiol Biomarkers Prev 9 2000 435 438
19. A. Koushik, R.W. Platt, and E.L. Franco p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review Cancer Epidemiol Biomarkers Prev 13 2004 11 22
20. T. Agorastos, A.F. Lambropoulos, T.C. Constantinidis, A. Kotsis, and J.N. Bontis P53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women Eur J Cancer Prev 9 2000 113 118
21. T. Li, Z. Lu, M. Guo, Q. Wu, K. Chen, H. Xing, Q. Mei, and Y. Ke P53 codon 72 polymorphism (C/G) and risk of human papillomavirus-associated carcinomas in China Cancer 95 2002 2571 2576
22. I. Zehbe, G. Voglino, E. Wilander, H. Delius, A. Marongiu, L. Edler, F. Klimek, S. Andersson, and M. Tommasino P53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development Cancer Res 61 2001 608 611
23. I. Zehbe, G. Voglino, E. Wilander, F. Genta, and M. Tommasino Codon 72 polymorphism of p53 and its association with cervical cancer Lancet 354 1999 218 219
24. S. Andersson, A. Rylander Strand, J. Sällström, and E. Wilander The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas Br J Cancer 85 2001 1153 1156
25. M.C. Abba, L.M. Villaverde, M.A. Gómez, F.N. Dulout, M.R. Laguens, and C.D. Golijow The p53 codon 72 genotypes in HPV infection and cervical disease Eur J Obstet Gynecol Reprod Biol 109 2003 63 66
26. M.R. Pillai, S. Sreevidya, B.H. Pollock, P.G. Jayaprakash, and B. Herman Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India J Cancer Res Clin Oncol 128 2002 627 631
27. G. Rezza, M. Giuliani, A. Garbuglia, D. Serraino, G. Cappiello, G. Migliore, M. Branca, A. Benedetto, and G. Ippolito Lack of association between P53 codon-72 polymorphism and squamous intraepithelial lesions in women with, or at risk for, human immunodeficiency virus and/or human papillomavirus infections Cancer Epidemiol Biomarkers Prev 10 2001 565 566
28. T. Yamashita, Y. Yaginuma, Y. Saitoh, K. Kawai, T. Kurakane, H. Hayashi, and M. Ishikawa Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of uterine cervix Carcinogenesis 20 1999 1733 1736
29. J.M. Ojeda, S. Ampuero, P. Rojas, R. Prado, J.E. Allende, S.A. Barton, R. Chakraborty, and F. Rothhammer p53 codon 72 polymorphism and risk of cervical cancer Biol Res 36 2003 279 283
30. R. Müllenbach, P.J. Lagoda, and C. Welter An efficient salt-chloroform extraction of DNA from blood and tissues Trends Genet 5 1989 391
31. D. Pinto, A. Vasconcelos, S. Costa, D. Pereira, H. Rodrigues, C. Lopes, and R. Medeiros HER2 polymorphism and breast cancer risk in Portugal Eur J Cancer Prev 13 2004 177 181
32. R. Craveiro, S. Costa, D. Pinto, L. Salgado, L. Carvalho, C. Castro, I. Bravo, C. Lopes, I. Silva, and R. Medeiros TP73 alterations in cervical carcinoma Cancer Genet Cytogenet 150 2004 116 121
33. R. Ribeiro, A. Vasconcelos, S. Costa, D. Pinto, A. Morais, J. Oliveira, F. Lobo, C. Lopes, and R. Medeiros Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease Prostate 59 2004 268 274
34. R. Medeiros, A. Vasconcelos, S. Costa, D. Pinto, F. Lobo, A. Morais, J. Oliveira, and C. Lopes Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer J Pathol 202 2004 330 335
35. R. Medeiros, A. Vasconcelos, S. Costa, D. Pinto, P. Ferreira, F. Lobo, A. Morais, J. Oliveira, and C. Lopes Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms Prostate 58 2004 414 420
36. R. Medeiros, D. Pereira, N. Afonso, C. Palmeira, C. Faleiro, C. Afonso-Lopes, M. Freitas-Silva, A. Vasconcelos, S. Costa, T. Osorio, and C. Lopes Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome Int J Clin Oncol 8 2003 156 161
37. P.M. Ferreira, R. Medeiros, A. Vasconcelos, S. Costa, D. Pinto, A. Morais, J. Oliveira, and C. Lopes Association between CYP2E1 polymorphisms and susceptibility to prostate cancer Eur J Cancer Prev 12 2003 205 211
38. R. Medeiros, A. Vasconcelos, S. Costa, D. Pinto, A. Morais, J. Oliveira, and C. Lopees Steroid hormone genotypes ARStuI and ER325 are linked to the progression of human prostate cancer Cancer Genet Cytogenet 141 2003 91 96
39. S. Costa, R. Medeiros, A. Vasconcelos, D. Pinto, and C. Lopes A slow acetylator genotype associated with an increased risk of advanced cervical cancer J Cancer Res Clin Oncol 128 2002 678 682
40. R. Medeiros, A. Morais, A. Vasconcelos, S. Costa, S. Carrilho, J. Oliveira, and C. Lopes Endothelial nitric oxide synthase gene polymorphisms and the shedding of circulating tumour cells in the blood of prostate cancer patients Cancer Lett 189 2003 85 90
41. R.M. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto, J. Oliveira, P. Ferreira, and C. Lopes Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7 Clin Cancer Res 8 2002 Nov 3433 3437
42. R. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto, J. Oliveira, R. Carvalho, and C. Lopes Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells Prostate 53 2002 88 94
43. R. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto, J. Oliveira, and C. Lopes Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer Eur J Cancer Prev 11 2002 343 350
44. R. Medeiros, A. Morais, A. Vasconcelos, S. Costa, D. Pinto, J. Oliveira, and C. Lopes The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population J Hum Genet 47 2002 413 418
45. A. Vasconcelos, R. Medeiros, I. Veiga, D. Pereira, S. Carrilho, C. Palmeira, C. Azevedo, and C.S. Lopes Analysis of estrogen receptor polymorphism in codon 325 by PCR-SSCP in breast cancer: association with lymph node metastasis Breast J 8 2002 226 229
46. G.J. Matlashewski, S. Tuck, D. Pim, P. Lamb, J. Schneider, and L.V. Crawford Primary structure polymorphism at amino acid residue 72 of human p53 Mol Cell Biol 7 1987 961 963
47. M. Scheffner, J.M. Huibregtse, R.D. Vierstra, and P.M. Howley The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53 Cell 75 1993 495 505
48. M. Thomas, A. Kalita, S. Labrecque, D. Pim, L. Banks, and G. Matlashewski Two polymorphic variants of wild-type p53 differ biochemically and biologically Mol Cell Biol 19 1999 1092 1100
49. A.N. Rosenthal, A. Ryan, R.M. Al-Jehani, A. Storey, C.A. Harwood, and I.J. Jacobs p53 codon 72 polymorphism and risk of cervical cancer in UK Lancet 352 1998 871 872
50. S. Lanham, I. Cambell, P. Watt, and R. Gornall P53 polymorphism and risk of cervical cancer [Letter] Lancet 352 1998 1631
51. A. Helland, A. Langerod, H. Johnsen, A.O. Olsen, E. Skovlund, and A.L. Borresen-Dale p53 polymorphism and risk of cervical cancer Nature 396 1998 530 531